THTX (Theratechnologies Inc.) Short-Term Debt to Capital
The daily price action for Theratechnologies Inc. (THTX) shown on this chart is accompanied by the 0.00 indicator. The business generates revenue by creating high-cost treatments for endocrine disruptions associated with HIV, which serve as a steady profit generator. Global market supply relies on strict temperature control during transport via certified hubs. The company's success is driven by advanced developments in cellular hormone adjustment to improve patient health.
Analytical breakdowns for Theratechnologies Inc.
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
Total Debt to Capital Theratechnologies Inc.|THTX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Theratechnologies|THTX - Aggregate Debt Obligations|Debts to Book Capitalization Theratechnologies, Inc.|THTX - Long-Term Debt Volume|Company Short-Term Debt Theratechnologies|Quick Liquidity theratech.com
- company profitability and valuation multiples indicators:
Fundamental valuation:Theratechnologies Inc
The ratio compares the volume of liabilities with a maturity of up to one year against the amount of equity, reacting to any changes in the borrowing structure. This metric determines the company's degree of dependence on rapid refinancing and the level of current credit load. For Theratechnologies Inc. (THTX), this risk is exacerbated by high debt service costs and uncertainty regarding clinical trial outcomes. The dynamics of short-term liabilities relative to equity visualize the business's resilience in the face of a limited sales market.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Current Liabilities to Capital|KALV: Short-Term Debt to Equity Ratio|Septerna Pharma - Short-Term Loans to Capital Ratio|PVLA: Short-Term Debt to Capital|savarapharma.com - Ratio of Short-Term Indebtedness to Capital|RIGL (Rigel Pharmaceuticals, Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital AnaptysBio Inc ANAB|Short-Term Debt to Equity Astria Pharma (ATXS)|ENGN (enGene Corp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital RAPT (RAPT Therapeutics)|Short-Term Debt to Capital Aerovate Therapeutics, Inc. JBIO|ACRS: Short-Term Debt to Equity Ratio|Kyverna Therapeutics Inc. - Short-Term Loans to Capital Ratio|TLSA: Short-Term Debt to Capital|Current Liabilities to Capital Cabaletta Bio Inc (CABA)|VTYX (Ventyx Biosciences) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio avalotx.com (AVTX)|Short-Term Debt to Capital ELDN|AGEN (Agenus, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Climb Bio, Inc. CLYM|ZURA: Short-Term Debt to Capital Ratio|ATYR - Short-Term Debt to Equity|Current Liabilities to Capital Adagene|ikenaoncology.com (IMA) - Short-Term Debt to Equity|STTK (Shattuck Labs) - Short-Term Debt to Equity|Short-Term Debt to Equity Equillium Inc|Current Liabilities to Capital Connect Pharma CNTB|Short-Term Debt to Capital IMUX|atarabio.com (ATRA) - Short-Term Indebtedness to Equity|Short-Term Debt to Capital IFRX (InflaRx)|Short-Term Debt to Capital Coefficient X4 Pharmaceuticals Inc. (XFOR)|Adicet - Short-Term Debt to Capital|Current Liabilities to Capital Celularity Inc.|INmune Bio, Inc. (INMB) - Short-Term Debt to Equity|BRNS - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio KZR|SABS: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital AKTX|Short-Term Debt to Capital Coefficient enlivex.com|Short-Term Debt to Equity Q32 Bio QTTB|GOVX: Short-Term Debt to Capital Ratio|Edesa Biotech - Short-Term Debt to Capital|iBio Inc (IBIO) - Short-Term Debt to Equity Ratio|CARM (carismatx.com) - Short-Term Debt to Equity Ratio|XTLB - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio BOLT|HCWB (HCW Biologics Inc) - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital APVO|AIM (aimimmuno.com) - Ratio of Short-Term Indebtedness to Capital|Aditxt, Inc. - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio GRI (GRI Bio Corporation)|XRTX: Short-Term Debt to Equity Ratio|HIND (reshapelifesciences.com) - Short-Term Debt to Capital Ratio|Revelation Biosciences, Inc. (REVB) - Short-Term Debt to Equity|Current Liabilities to Equity INDP (Indaptus Therapeutics Inc)|SCNI (Scinai) - Short-Term Debt to Capital|CALI: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital AFMD|Short-Term Debt to Capital allakos.com (ALLK)|Short-Term Debt to Equity HOOKIPA Pharma HOOK|Ratio of Short-Term Indebtedness to Capital IGMS|ITOS - Short-Term Debt to Equity|Ocean Biomedical Corp (OCEA) - Short-Term Debt to Equity Ratio|TCBP: Short-Term Debt to Capital|thirdharmonicbio.com (THRD) - Short-Term Debt to Capital